发明名称 METHOD FOR DETERMINING INDICATIONS IN FAVOR OF ALPHA-INTERFERON TREATMENT TO BE ADMINISTERED TO CHRONIC MYELOLEUKEMIA PATIENTS
摘要 medicine. SUBSTANCE: method involves determining t(9,22)(q34, q11) translocation chromosomes type. Chymeric b3a2 transcript being detected, alpha-interferon treatment of chronic myeloleukemia patients is to be indicated. EFFECT: enhanced accuracy of the method.
申请公布号 RU2169368(C1) 申请公布日期 2001.06.20
申请号 RU20000127652 申请日期 2000.10.31
申请人 SANKT-PETERBURGSKIJ GOSUDARSTVENNYJ MEDITSINSKIJ U;NIVERSITET IM AKAD I P PAVLOVA 发明人 BOGDANOV K.V.;FROLOVA O.I.;MARINETS O.V.;ZARAJSKIJ M.I.;AFANAS'EV B.V.;ZARITSKIJ A.JU.
分类号 G01N33/48;(IPC1-7):G01N33/48 主分类号 G01N33/48
代理机构 代理人
主权项
地址